The Protein Myth: Our Obsession With Protein and How It Is Killing US

Houston Methodist

G. Davis

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Advancing Type 2 Diabetes Care with Omnipod® 5

Omnipod®

V. Shah, D. Kruger, T. Ly

Medications for Weight Loss: The New Satiety Hormones

Scripps Health

K. Fujioka

Should Colchicine Become Standard Therapy for CAD?

Canadian Collaborative Research Network

P. Ridker

Optimizing Omnipod® 5 for Better Patient Outcomes (featuring Jennife…

Omnipod®

J. Okemah

Do Triglycerides Cause Heart Disease?

National Lipid Association

I. Goldberg

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

Mind over diabetes: a psychologist’s take on the freedom of Omnipod®…

Omnipod®

M. Heyman

MAFLD: What Is It?

Houston Methodist

D. Victor

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Omnipod®

F. Pasquel

Tirzepatide Updates

Diana Isaacs

Incretin-based Therapies in the Management of Obesity and its Comorb…

Michigan Medicine

A. Rothberg

Weightloss in Menopause

Susan Brian

Wearable Devices in Sports Medicine

UCSF School of Medicine

N. Hatamiya

Getting Patients Started with an Obesity Treatment Option for Adults

Lilly Obesity

E. Lazarus

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne